Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2012 | 2 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients.
Cancer Immunol Immunother. 2012 Sep;61(9):1395-405. doi: 10.1007/s00262-011-1197-x. Epub 2012 Jan 20.
Cancer Immunol Immunother. 2012.
PMID: 22270713
Free PMC article.
IRX-2, a novel biologic, favors the expansion of T effector over T regulatory cells in a human tumor microenvironment model.
Schilling B, Harasymczuk M, Schuler P, Egan JE, Whiteside TL.
Schilling B, et al.
J Mol Med (Berl). 2012 Feb;90(2):139-47. doi: 10.1007/s00109-011-0813-8. Epub 2011 Sep 14.
J Mol Med (Berl). 2012.
PMID: 21915712
Free PMC article.
Item in Clipboard
Cite
Cite